Brief: BB Biotech FY Net Result Swings To Loss Of CHF 471 Million
Jan 18 (Reuters) - BB Biotech AG BION.S :
* BB BIOTECH INVESTS GAINS OF M&A TRANSACTIONS IN NEW
TECHNOLOGIES
- DIVIDEND OF CHF 3.05 PROPOSED
* NET LOSS OF CHF 643 MN FOR Q4 AND CHF 471 MN FOR YEAR AS A
WHOLE
Source text for Eikon: ID:nEQ2PcDkra
Further company coverage: BION.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Bb Biotech AG
See all newsBB Biotech Q3 net profit falls, NAV underperforms biotech index
Brief: BB Biotech Reports Q3 2026 Net Profit CHF 175 Mln
Brief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million